These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

653 related items for PubMed ID: 19001816

  • 21. Anti-human leukocyte antigen and donor-specific antibodies detected by luminex posttransplant serve as biomarkers for chronic rejection of renal allografts.
    Lachmann N, Terasaki PI, Budde K, Liefeldt L, Kahl A, Reinke P, Pratschke J, Rudolph B, Schmidt D, Salama A, Schönemann C.
    Transplantation; 2009 May 27; 87(10):1505-13. PubMed ID: 19461487
    [Abstract] [Full Text] [Related]

  • 22. De novo production of donor-specific anti-HLA alloantibodies in early acute humoral renal allograft rejection.
    Spriewald BM, Hugo C.
    Clin Transpl; 2006 May 27; ():469-72. PubMed ID: 18365405
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. 2012 annual literature review of donor-specific HLA antibodies after organ transplantation.
    Kaneku H.
    Clin Transpl; 2012 May 27; ():207-17. PubMed ID: 23721024
    [Abstract] [Full Text] [Related]

  • 25. The role of HLA-specific antibodies in kidney transplant rejection: published studies and local data.
    Worthington JE, Martin S, Barker AJ, McWilliam LJ, Dyer PA.
    Clin Transpl; 2006 May 27; ():349-61. PubMed ID: 18365389
    [Abstract] [Full Text] [Related]

  • 26. Clinical significance of anti-HLA antibodies detected by Luminex: enhancing the interpretation of CDC-BXM and important post-transplantation monitoring tools.
    Eng HS, Bennett G, Bardy P, Coghlan P, Russ GR, Coates PT.
    Hum Immunol; 2009 Aug 27; 70(8):595-9. PubMed ID: 19527759
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Relevance of different antibody detection methods for the prediction of antibody-mediated rejection and deceased-donor kidney allograft survival.
    Vlad G, Ho EK, Vasilescu ER, Colovai AI, Stokes MB, Markowitz GS, D'Agati VD, Cohen DJ, Ratner LE, Suciu-Foca N.
    Hum Immunol; 2009 Aug 27; 70(8):589-94. PubMed ID: 19375470
    [Abstract] [Full Text] [Related]

  • 30. C4d deposition in lung allografts is associated with circulating anti-HLA alloantibody.
    Ionescu DN, Girnita AL, Zeevi A, Duquesnoy R, Pilewski J, Johnson B, Studer S, McCurry KR, Yousem SA.
    Transpl Immunol; 2005 Oct 27; 15(1):63-8. PubMed ID: 16223674
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Development of non-donor-specific HLA antibodies after kidney transplantation: frequency and clinical implications.
    Briggs D, Zehnder D, Higgins RM.
    Contrib Nephrol; 2009 Oct 27; 162():107-16. PubMed ID: 19001818
    [Abstract] [Full Text] [Related]

  • 33. Emerging role of donor-specific anti-human leukocyte antigen antibody determination for clinical management after solid organ transplantation.
    Zeevi A, Lunz JG, Shapiro R, Randhawa P, Mazariegos G, Webber S, Girnita A.
    Hum Immunol; 2009 Aug 27; 70(8):645-50. PubMed ID: 19527760
    [Abstract] [Full Text] [Related]

  • 34. Sensitization after kidney transplantation.
    Akalin E, Pascual M.
    Clin J Am Soc Nephrol; 2006 May 27; 1(3):433-40. PubMed ID: 17699242
    [Abstract] [Full Text] [Related]

  • 35. Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation.
    Tait BD, Süsal C, Gebel HM, Nickerson PW, Zachary AA, Claas FH, Reed EF, Bray RA, Campbell P, Chapman JR, Coates PT, Colvin RB, Cozzi E, Doxiadis II, Fuggle SV, Gill J, Glotz D, Lachmann N, Mohanakumar T, Suciu-Foca N, Sumitran-Holgersson S, Tanabe K, Taylor CJ, Tyan DB, Webster A, Zeevi A, Opelz G.
    Transplantation; 2013 Jan 15; 95(1):19-47. PubMed ID: 23238534
    [Abstract] [Full Text] [Related]

  • 36. Expansion of humoral donor-specific alloreactivity after renal transplantation correlates with impaired graft outcome.
    Varnavidou-Nicolaidou A, Iniotaki-Theodoraki AG, Doxiadis II, Georgiou D, Patargias T, Stavropoulos-Giokas C, Kyriakides G.
    Hum Immunol; 2005 Sep 15; 66(9):985-8. PubMed ID: 16360838
    [Abstract] [Full Text] [Related]

  • 37. Post transplant development of MICA and anti-HLA antibodies is associated with acute rejection episodes and renal allograft loss.
    Panigrahi A, Gupta N, Siddiqui JA, Margoob A, Bhowmik D, Guleria S, Mehra NK.
    Hum Immunol; 2007 May 15; 68(5):362-7. PubMed ID: 17462503
    [Abstract] [Full Text] [Related]

  • 38. Post-transplant development of C1q-positive HLA antibodies and kidney graft survival.
    Piazza A, Poggi E, Ozzella G, Adorno D.
    Clin Transpl; 2013 May 15; ():367-75. PubMed ID: 25095531
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 33.